GlaxoSmithKline - 33 Year Stock Price History | GSK

Historical daily share price chart and data for GlaxoSmithKline since 1986 adjusted for splits. The latest closing stock price for GlaxoSmithKline as of April 18, 2019 is 39.85.
  • The all-time high GlaxoSmithKline stock price is 42.74, which is 7.3% above the current share price.
  • The GlaxoSmithKline 52-week high stock price is 41.88, which is 5.1% above the current share price.
  • The GlaxoSmithKline 52-week low stock price is 36.53, which is 8.3% below the current share price.
  • The average GlaxoSmithKline stock price for the last 52 weeks is 39.21.
GlaxoSmithKline Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 39.9284 37.3302 41.8800 37.2810 39.8500 5.83%
2018 37.9185 34.4798 41.2623 33.1353 37.6554 13.71%
2017 36.5540 34.4179 40.3280 32.3604 33.1167 -2.96%
2016 35.7984 33.6030 39.4277 32.3154 34.1255 1.81%
2015 35.0278 33.3481 38.9815 30.7895 33.5199 -0.35%
2014 38.6787 39.4487 42.7362 32.5059 33.6393 -15.68%
2013 36.4664 31.4215 39.8971 31.2791 39.8971 28.90%
2012 31.3782 31.1844 33.3249 29.4662 30.9516 0.67%
2011 27.4465 25.0974 30.8206 23.2303 30.7465 22.60%
2010 23.8009 26.0462 26.4257 20.1558 25.0782 -2.08%
2009 21.6051 21.2943 26.0099 15.9261 25.6098 19.30%
2008 24.2790 27.4966 29.7930 18.4432 21.4671 -22.27%
2007 28.7968 28.4038 31.6241 26.2360 27.6172 -0.83%
2006 27.9886 26.0436 30.3272 25.6296 27.8495 7.95%
2005 24.6359 23.4617 27.3570 22.0397 25.7983 9.87%
2004 20.7086 22.3468 23.5361 19.0217 23.4815 5.55%
2003 19.0633 17.7558 22.6188 15.2922 22.2466 28.80%
2002 19.3708 22.3162 22.7728 14.9103 17.2717 -22.56%
2001 23.8285 24.6270 25.6580 21.5068 22.3027 -9.63%
2000 24.1035 23.3562 27.1432 19.3374 24.6799 5.06%
1999 24.4726 28.8829 30.7639 20.2481 23.4907 -16.98%
1998 23.6708 19.2294 28.2966 19.2294 28.2966 47.92%
1997 15.8109 12.3308 19.1775 11.8394 19.1296 53.28%
1996 10.8834 10.6545 13.3645 9.0262 12.4801 17.13%
1995 8.8030 7.5599 10.6545 6.8825 10.6545 44.39%
1994 6.5687 7.2990 7.6975 5.6079 7.3788 2.30%
1993 6.3855 7.9472 7.9472 5.0141 7.2126 -8.78%
1992 8.9592 10.3804 11.3184 7.4078 7.9072 -23.54%
1991 7.1132 5.2205 10.3413 4.9411 10.3413 98.87%
1990 4.3924 3.9494 5.4983 3.5076 5.1999 30.40%
1989 3.4504 2.8743 4.0444 2.7623 3.9877 38.74%
1988 2.6475 2.7423 3.0042 2.3439 2.8743 8.37%
1987 3.4207 2.1906 4.3413 2.1906 2.6522 21.07%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $98.852B $41.140B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $368.953B 16.73
Pfizer (PFE) United States $234.424B 13.13
Merck (MRK) United States $197.334B 16.86
Novartis AG (NVS) Switzerland $176.507B 15.01
Eli Lilly (LLY) United States $119.326B 20.72
Novo Nordisk (NVO) Denmark $118.242B 19.13
AbbVie (ABBV) United States $114.422B 9.81
Sanofi (SNY) France $103.609B 12.79
AstraZeneca (AZN) United Kingdom $98.276B 11.21
Bristol-Myers Squibb (BMY) United States $74.378B 11.44